Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
Clinical trial NCT01158105 · UNKNOWN
Trial details
- NCT number
- NCT01158105
- Sponsor
- Baylor Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.